Retatrutide Delivers Substantial Weight Loss in Type 2 Diabetes

(MedPage Today) -- The investigational triple agonist retatrutide substantially improved glycemic control and body weight in adults with obesity and type 2 diabetes, a phase III trial showed.
Among 1,152 participants, average percentage of body...